|
Market Closed -
Japan Exchange
02:30:00 2026-08-14 EDT
|
5-day change | 1st Jan Change | ||
| 2,430.00 JPY | +0.52% |
|
+2.08% | +11.85% |
| 07-31 | Ono Pharmaceutical's Profit Rises 37% in Fiscal Q1 | MT |
| 07-30 | Ono Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended June 30, 2026 | CI |
| Market Cap | 1,142B 7.18B 6.2B 5.82B 5.3B 9.96B 686B 10.12B 68.24B 26.68B 344B 26.94B 26.36B | P/E 2027 * |
15.8x | P/E 2028 * | 18.1x |
|---|---|---|---|---|---|
| Enterprise Value | 941B 5.91B 5.11B 4.8B 4.36B 8.2B 565B 8.34B 56.22B 21.98B 283B 22.2B 21.72B | EV / Sales 2027 * |
2.06x | EV / Sales 2028 * | 1.99x |
| Free-Float |
80.98% | Yield 2027 * |
3.22% | Yield 2028 * | 3.19% |
Last Transcript: Ono Pharmaceutical Co., Ltd.
| 1 day | +0.52% | ||
| 1 week | +2.08% | ||
| Current month | +1.93% | ||
| 1 month | -0.10% | ||
| 3 months | -5.58% | ||
| 6 months | -4.20% | ||
| Current year | +11.85% |
| 1 week | 2,359 |  | 2,449 |
| 1 month | 2,264.5 | | 2,514.5 |
| Current year | 2,114.5 | | 2,674.5 |
| 1 year | 1,596 | | 2,674.5 |
| 3 years | 1,474 | | 2,966.5 |
| 5 years | 1,474 | | 3,990 |
| 10 years | 1,474 | | 3,990 |
| Manager | Title | Age | Since |
|---|---|---|---|
Gyo Sagara
CEO | Chief Executive Officer | 67 | 2024-03-31 |
Masaki Ito
DFI | Director of Finance/CFO | - | 2026-03-31 |
Toichi Takino
PSD | President | 57 | 2024-03-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Gyo Sagara
CHM | Chairman | 67 | 2024-03-31 |
Toichi Takino
BRD | Director/Board Member | 57 | 2020-05-31 |
Masao Nomura
BRD | Director/Board Member | 77 | 2018-06-25 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.52% | +2.08% | +40.75% | -12.45% | 7.18B | |
| -0.10% | -0.77% | +17.58% | +70.16% | 48.43B | |
| -3.26% | -5.31% | +53.19% | +117.23% | 39.72B | |
| -0.60% | -0.94% | -7.29% | +17.35% | 12.25B | |
| -2.75% | +1.88% | +14.81% | +76.92% | 11.84B | |
| -0.19% | -0.38% | +30.40% | +135.91% | 9.06B | |
| +1.56% | +5.52% | +23.46% | +39.78% | 7.57B | |
| -0.07% | +1.72% | +13.39% | +190.65% | 6.84B | |
| -2.51% | -3.14% | -27.46% | +24.20% | 5.77B | |
| +1.61% | +5.26% | +36.74% | +111.25% | 4.8B | |
| Average | -0.58% | +1.77% | +19.56% | +77.10% | 15.35B | |
| Weighted average by Cap. | -1.09% | +1.12% | +25.45% | +82.10% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 457B 2.87B 2.48B 2.33B 2.12B 3.98B 275B 4.05B 27.31B 10.68B 138B 10.78B 10.55B | 447B 2.81B 2.43B 2.28B 2.07B 3.9B 269B 3.96B 26.73B 10.45B 135B 10.55B 10.32B |
| Net income | 72.16B 453M 392M 368M 335M 629M 43.36B 640M 4.31B 1.69B 21.72B 1.7B 1.67B | 63.11B 397M 343M 322M 293M 550M 37.93B 559M 3.77B 1.47B 18.99B 1.49B 1.46B |
| Net Debt | -201B -1.26B -1.09B -1.03B -933M -1.75B -121B -1.78B -12.02B -4.7B -60.51B -4.74B -4.64B | -250B -1.57B -1.36B -1.27B -1.16B -2.18B -150B -2.21B -14.92B -5.83B -75.14B -5.89B -5.76B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-08-14 | JP¥2,430.00 | +0.52% | 1,323,900 |
| 26-08-13 | JP¥2,417.50 | +0.06% | 1,481,200 |
| 26-08-12 | JP¥2,416.00 | -0.12% | 1,622,100 |
| 26-08-10 | JP¥2,419.00 | +1.62% | 1,335,600 |
| 26-08-07 | JP¥2,380.50 | +1.82% | 1,307,700 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- 4528 Stock
Select your edition
All financial news and data tailored to specific country editions
